Overview

Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
This study is aimed to evaluate the efficacy, safety and tolerability of oxcarbazepine monotherapy in adults with partial seizures.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Carbamazepine
Oxcarbazepine